In vivo and in vitro expression of the plasminogen activators and urokinase type plasminogen activator receptor (u-PAR) in the pig oviduct

Animal Reproduction Science

Volumn 136, Issue 1-2, 2012, Pages 90-99

  Roldán Olarte, Mariela ^a,b   García, Daniela C ^a   Jiménez Díaz, María ^b   Valdecantos, Pablo A ^b   Miceli, Dora C ^a,b  

^a Instituto Superior de Investigaciones Biologicas   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Oviduct; Pig; Plasminogen activators; Porcine; U PAR

Indexed keywords

ESTRADIOL; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROKINASE RECEPTOR;

ANIMAL; ARTICLE; DRUG EFFECT; ENZYMOLOGY; ESTRUS CYCLE; FEMALE; GENETICS; METABOLISM; OVIDUCT; PHYSIOLOGY; SWINE;

ANIMALS; ESTRADIOL; ESTROUS CYCLE; FEMALE; OVIDUCTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGESTERONE; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RNA, MESSENGER; SWINE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

SUIDAE; SUS;

EID: 84870562003     PISSN: 03784320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anireprosci.2012.09.013     Document Type: Article

References (45)

1. Argañaraz M.E., Valdecantos P.A., Abate C.M., Miceli D.C. Rat Lefty2/EBAF gene: isolation and expression analysis in the oviduct during the early pregnancy stage. Genes Genet. Syst. 2007, 82:171-175.
2. Aflalo E.D., Sod-Moriah U.A., Potashnik G., Har-Vardi I. EGF increases expression and activity of PAs in preimplantation rat embryos and their implantation rate. Reprod. Biol. Endocrinol. 2007, 5:4.
3. Blasi F., Sidenius N. The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling. FEBS Lett. 2010, 584:1923-1930.
4. Blasi F., Vassalli J.D., Dano K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol. 1987, 104:801-804.
5. Buhi W.C. Characterization and biological roles of oviduct-specific, oestrogen-dependent glycoprotein. Reproduction 2002, 123:355-362.
6. Buhi W.C., Alvarez I.M. Identification, characterization and localization of three proteins expressed by the porcine oviduct. Theriogenology 2003, 60:225-238.
7. Cubellis M.V., Wun T.C., Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 1990, 9:1079-1085.
8. Cox M.W., Fu W., Chai H., Paladugu R., Lin P.H., Lumsden A.B., Yao Q., Chen C. Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J. Surg. Res. 2005, 124:104-111.
9. Czekay R.P., Wilkins-Port C.E., Higgins S.P., Freytag J., Overstreet J.M., Klein R.M., Higgins C.E., Samarakoon R., Higgins P.J. PAI-1: an integrator of cell signaling and migration. Int. J. Cell. Biol. 2011, 2011:562481.
10. D'Alessandris C., Canipari R., Di Giacomo M., Epifano O., Camaioni A., Siracusa G., Salustri A. Control of mouse cumulus cell-oocyte complex integrity before and after ovulation: plasminogen activator synthesis and matrix degradation. Endocrinology 2001, 142:3033-3040.
11. Dass K., Ahmad A., Azmi A.S., Sarkar S.H., Sarkar F.H. Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 2008, 34:122-136.
12. Dumler I., Weis A., Mayboroda O.A., Maasch C., Jerke U., Haller H., Gulba D.C. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J. Biol. Chem. 1998, 273:315-321.
13. Gabler C., Killian G.J., Einspanier R. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle. Reproduction 2001, 122:121-130.
14. Geiger M., Zechmeister-Machhart M., Uhrin P., Hufnagl P., Ecke S., Priglinger U., Xu J., Zheng X., Binder B.R. Protein C inhibitor (PCI). Immunopharmacology 1996, 32:53-56.
15. Haj-Yehia A., Nassar T., Sachais B.S., Kuo A., Bdeir K., Al-Mehdi A.B., Mazar A., Cines D.B., Higazi A.A. Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo. FASEB J. 2000, 14:1411-1422.
16. Huarte J., Vassalli J.D., Belin D., Sakkas D. Involvement of the plasminogen activator/plasmin proteolytic cascade in fertilization. Dev. Biol. 1993, 157:539-546.
17. Ijaz A., Lambert R.D., Sirard M.A. In vitro-cultured bovine granulosa and oviductal cells secrete sperm motility-maintaining factor(s). Mol. Reprod. Dev. 1994, 37:54-60.
18. Irigoyen J.P., Munoz-Canoves P., Montero L., Koziczak M., Nagamine Y. The plasminogen activator system: biology and regulation. Cell. Mol. Life Sci. 1999, 56:104-132.
19. Jiménez Díaz M., Giunta S., Valz-Gianinet J., Pereyra-Alfonso S., Flores V., Miceli D. Proteases with plasminogen activator activity in hamster oviduct. Mol. Reprod. Dev. 2000, 55:47-54.
20. Katz E., Streuli C.H. The extracellular matrix as an adhesion checkpoint for mammary epithelial function. Int. J. Biochem. Cell Biol. 2007, 39:715-726.
21. Killian G.J. Evidence for the role of oviduct secretions in sperm function, fertilization and embryo development. Anim. Reprod. Sci. 2004, 82-83:141-153.
22. Kouba A.J., Alvarez I.M., Buhi W.C. Identification and localization of plasminogen activator inhibitor-1 within the porcine oviduct. Biol. Reprod. 2000, 62:501-510.
23. Kouba A.J., Burkhardt B.R., Alvarez I.M., Goodenow M.M., Buhi W.C. Oviductal plasminogen activator inhibitor-1 (PAI-1): mRNA, protein, and hormonal regulation during the estrous cycle and early pregnancy in the pig. Mol. Reprod. Dev. 2000, 56:378-386.
24. Kwaan H.C., McMahon B. The role of plasminogen-plasmin system in cancer. Cancer Treat. Res. 2009, 148:43-66.
25. Le Magueresse-Battistoni B. Serine proteases and serine protease inhibitors in testicular physiology: the plasminogen activation system. Reproduction 2007, 134:721-729.
26. Liu Y.X. Plasminogen activator/plasminogen activator inhibitors in ovarian physiology. Front. Biosci. 2004, 9:3356-3373.
27. Liu Y.X. Involvement of plasminogen activator and plasminogen activator inhibitor type 1 in spermatogenesis, sperm capacitation, and fertilization. Semin. Thromb. Hemost. 2007, 33:29-40.
28. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
29. Mariscal D.V., Bergfeld E.G., Cupp A.S., Kojima F.N., Fike K.E., Sanchez T., Wehrman M.E., Johnson R.K., Kittok R.J., Ford J.J., Kinder J.E. Concentrations of gonadotropins, estradiol and progesterone in sows selected on an index of ovulation rate and embryo survival. Anim. Reprod. Sci. 1998, 54:31-43.
30. Martinez-Hernandez M.G., Baiza-Gutman L.A., Castillo-Trapala A., Armant D.R. Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9. Reproduction 2011, 141:227-239.
31. Ny T., Wahlberg P., Brandstrom I.J. Matrix remodeling in the ovary: regulation and functional role of the plasminogen activator and matrix metalloproteinase systems. Mol. Cell. Endocrinol. 2002, 187:29-38.
32. Papanikolaou T., Amiridis G.S., Dimitriadis I., Vainas E., Rekkas C.A. Effect of plasmin, plasminogen activators and a plasmin inhibitor on bovine in vitro embryo production. Reprod. Fertil. Dev. 2008, 20:320-327.
33. Pereyra-Alfonso S., Scicolone G., Fiszer de Plazas S., Saavedra J.P., Flores V. Current Triton X-100 treatments do not allow a complete plasminogen activator extraction from developing nervous tissue. Neurochem. Res. 1995, 20:137-142.
34. Plouët J., Moro F., Bertagnolli S., Coldeboeuf N., Mazarguil H., Clamens S., Bayard F. Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. J. Biol. Chem. 1997, 272:13390-13396.
35. Roldán-Olarte M., Jimenez-Diaz M., Miceli D.C. Plasminogen detection in oocytes and plasminogen activator activities in the porcine oviduct during the estrous cycle. Zygote 2005, 13:115-123.
36. Saksela O., Rifkin D.B. Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 1988, 4:93-126.
37. Saksela O., Rifkin D.B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol. 1990, 110:767-775.
38. Sirotkin A.V., Nitray J. Steroid hormones regulate cAMP and cGMP production by porcine granulosa cells in vitro. J. Steroid Biochem. Mol. Biol. 1993, 46:573-577.
39. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 2010, 11:23-36.
40. Soutar R.L., Dillon J., Ralston S.H. Control genes for reverse-transcription-polymerase chain reaction: a comparison of beta actin and glyceraldehyde phosphate dehydrogenase. Br. J. Haematol. 1997, 97:247-248.
41. Sudol M., Reich E. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line. Biochem. J. 1984, 219:971-978.
42. Tang H., Kerins D.M., Hao Q., Inagami T., Vaughan D.E. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J. Biol. Chem. 1998, 273:18268-18272.
43. Thomas P.G., Ignotz G.G., Ball B.A., Miller P.G., Brinsko S.P., Currie B. Isolation, culture, and characterization of equine oviduct epithelial cells in vitro. Mol. Reprod. Dev. 1995, 41:468-478.
44. Tsantarliotou M.P., Zervos I.A., Vatzias G., Billinis C., Taitzoglou I.A., Kokolis N.A. Plasminogen activator activity in the porcine oviduct during the oestrous cycle. Theriogenology 2005, 64:1007-1015.
45. Wallen P., Bergsdorf N., Ranby M. Purification and identification of two structural variants of porcine tissue plasminogen activator by affinity adsorption on fibrin. Biochim. Biophys. Acta 1982, 719:318-328.